Dengue Vaccine Market

Dengue Vaccine Market

Dengue Vaccine Market: Contribution of NGOs for Better Vaccine Access Expected to Drive the Market in Lower Income Countries: Global Industry Analysis & Opportunity Assessment, 2017 – 2027

  • XPLREP5075

  • March, 2017

  • 98 Pages

  • Pharmaceutical

XploreMR in its report titled “Dengue Vaccine Market: Global Industry Analysis and Opportunity Assessment, 2017–2027” offers detailed insights and in-depth research on the global dengue vaccine market over a 10 year forecast period 2017 – 2027. The report covers the important factors driving the growth of the global dengue vaccine market, untapped opportunities for manufacturers, trends and developments shaping the dynamics of the global dengue vaccine market and other insights across various key segments. The report identifies the drivers and restraints affecting the growth of the global dengue vaccine market. Changing trends are also analysed and incorporated in the report to provide exhaustive information about the market resulting in better decision making. Macroeconomic factors and forecast factors that directly and indirectly affect the growth of the global dengue vaccine market are also incorporated in the report. 

Report Description

The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global dengue vaccine market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies developing the dengue vaccine in the global dengue vaccine market are presented in the report. To understand and assess opportunities in this market, the report offers market forecast on the basis of end user and regions. The report provides analysis of the global dengue vaccine market in terms of market value (US$ Mn).

The report begins with the market introduction followed by the global market overview of the dengue vaccine. The market dynamics section includes XploreMR’ analysis of key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global dengue vaccine market. The report also analyses various issues of Dengvaxia, tiered pricing of dengue vaccine, sales channel strategy adoption, pipeline assessment, promotional activities adopted by Sanofi, and epidemiology of dengue.

Market Segmentation

 By Product
  • CYD-TDV (Dengvaxia)
 By End User 
  • Hospitals
  • Government Institutes
  • Non-Governmental Organizations (NGOs)
 By Region
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Middle East and Africa
  • Japan

Research Methodology

In the final section of the report, a competitive landscape has been included to provide a dashboard view of key companies operating in the global dengue vaccine market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the global dengue vaccine market and the potential players. This section also includes market strategies and SWOT analysis of the main players operational in the global dengue vaccine market.

We have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the global dengue vaccine market and to identify growth opportunities for companies operating in the global dengue vaccine market. Another important feature of our report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity analysis is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered in the global dengue vaccine market. Furthermore, to understand key market segments in terms of their growth and performance in the global dengue vaccine market, XploreMR has developed a unique market attractiveness index to help providers identify existing market opportunities.  

The various sub segments of the global dengue vaccine market have also been analysed in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identifying various key trends in the global dengue vaccine market.

Purchase Options
Dengue Vaccine Market: Contribution of NGOs for Better Vaccine Access Expected to Drive the Market in Lower Income Countries: Global Industry Analysis & Opportunity Assessment, 2017 – 2027
Buy Now
Custom Market Research Services

Custom Market Research Services

xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough

Why Choose XploreMR

Why Choose XploreMR
  • Analyst Support

    Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.

  • Country-wise Analysis & Forecasting

    As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.

  • High Quality At Competitive Pricing

    We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information

Popular Reports

report
Global Market Study on Traditional Chinese Medicine: Favourable Regulatory & Reimbursement Scenario Supporting Market Expansion

Traditional Chinese Medicine Market - Scope of the Report A latest publication by XploreMR on the global traditional Chinese medicine market evaluates the opportunities and current market ...

report
Vaginitis Treatment Drugs Market - Global Industry Analysis and Opportunity Assessment, 2020-2030

A recent market study published by XploreMR on the Vaginitis Treatment Drugs Market including global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensiv ...